|
1
|
Frattini V, Trifonov V, Chan JM, Castano
A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F, et al: The
integrated landscape of driver genomic alterations in glioblastoma.
Nat Genet. 45:1141–1149. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer Genome Atlas Research Network, ;
Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA,
Rheinbay E, Miller CR, Vitucci M, et al: Comprehensive, integrative
genomic analysis of diffuse lower-grade gliomas. N Engl J Med.
372:2481–2498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: Primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro Oncol. 14 Suppl 5:v1–v49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Network TC: Corrigendum: Comprehensive
genomic characterization defines human glioblastoma genes and core
pathways. Nature. 494:5062013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Viana-Pereira M, Lopes JM, Little S,
Milanezi F, Basto D, Pardal F, Jones C and Reis RM: Analysis of
EGFR overexpression, EGFR gene amplification and the EGFRvIII
mutation in Portuguese high-grade gliomas. Anticancer Res.
28:913–920. 2008.PubMed/NCBI
|
|
7
|
Johnson H, Del Rosario AM, Bryson BD,
Schroeder MA, Sarkaria JN and White FM: Molecular characterization
of EGFR and EGFRvIII signaling networks in human glioblastoma tumor
xenografts. Mol Cell Proteomics. 11:1724–1740. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ramnarain DB, Park S, Lee DY, Hatanpaa KJ,
Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, et
al: Differential gene expression analysis reveals generation of an
autocrine loop by a mutant epidermal growth factor receptor in
glioma cells. Cancer Res. 66:867–874. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mukherjee B, McEllin B, Camacho CV,
Tomimatsu N, Sirasanagandala S, Nannepaga S, Hatanpaa KJ, Mickey B,
Madden C, Maher E, et al: EGFRvIII and DNA double-strand break
repair: A molecular mechanism for radioresistance in glioblastoma.
Cancer Res. 69:4252–4259. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shinojima N, Tada K, Shiraishi S, Kamiryo
T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, et
al: Prognostic value of epidermal growth factor receptor in
patients with glioblastoma multiforme. Cancer Res. 63:6962–6970.
2003.PubMed/NCBI
|
|
11
|
Verhaak RG, Hoadley KA, Purdom E, Wang V,
Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al:
Integrated genomic analysis identifies clinically relevant subtypes
of glioblastoma characterized by abnormalities in PDGFRA, IDH1,
EGFR, and NF1. Cancer Cell. 17:98–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun Y, Zhang W, Chen D, Lv Y, Zheng J,
Lilljebjörn H, Ran L, Bao Z, Soneson C, Sjögren HO, et al: A glioma
classification scheme based on coexpression modules of EGFR and
PDGFRA. Proc Natl Acad Sci USA. 111:pp. 3538–3543. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fabbro M, Zhou BB, Takahashi M, Sarcevic
B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y and
Khanna KK: Cdk1/Erk2- and Plk1-dependent phosphorylation of a
centrosome protein, Cep55, is required for its recruitment to
midbody and cytokinesis. Dev Cell. 9:477–488. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao WM, Seki A and Fang G: Cep55, a
microtubule-bundling protein, associates with centralspindlin to
control the midbody integrity and cell abscission during
cytokinesis. Mol Biol Cell. 17:3881–3896. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Doxsey S: Duplicating dangerously: Linking
centrosome duplication and aneuploidy. Mol Cell. 10:439–440. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martinez-Garay I, Rustom A, Gerdes HH and
Kutsche K: The novel centrosomal associated protein CEP55 is
present in the spindle midzone and the midbody. Genomics.
87:243–253. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ,
Tsou AP, Lee YC, Lin TC, Hsu SL, Lin WJ, et al: FLJ10540-elicited
cell transformation is through the activation of PI3-kinase/AKT
pathway. Oncogene. 26:4272–4283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jeffery J, Sinha D, Srihari S, Kalimutho M
and Khanna KK: Beyond cytokinesis: The emerging roles of CEP55 in
tumorigenesis. Oncogene. 35:683–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carlton JG and Martin-Serrano J: Parallels
between cytokinesis and retroviral budding: A role for the ESCRT
machinery. Science. 316:1908–1912. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee HH, Elia N, Ghirlando R,
Lippincott-Schwartz J and Hurley JH: Midbody targeting of the ESCRT
machinery by a noncanonical coiled coil in CEP55. Science.
322:576–580. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen CH, Lai JM, Chou TY, Chen CY, Su LJ,
Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, et al: VEGFA
upregulates FLJ10540 and modulates migration and invasion of lung
cancer via PI3K/AKT pathway. PLoS One. 4:e50522009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tao J, Zhi X, Tian Y, Li Z, Zhu Y, Wang W,
Xie K, Tang J, Zhang X, Wang L and Xu Z: CEP55 contributes to human
gastric carcinoma by regulating cell proliferation. Tumor Biol.
35:4389–4399. 2014. View Article : Google Scholar
|
|
23
|
Carter SL, Eklund AC, Kohane IS, Harris LN
and Szallasi Z: A signature of chromosomal instability inferred
from gene expression profiles predicts clinical outcome in multiple
human cancers. Nat Genet. 38:1043–1048. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang G, Liu M, Wang H, Yu S, Jiang Z, Sun
J, Han K, Shen J, Zhu M, Lin Z, et al: Centrosomal protein of 55
regulates glucose metabolism, proliferation and apoptosis of glioma
cells via the Akt/mTOR signaling pathway. J Cancer. 7:1431–1440.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gemenetzidis E, Bose A, Riaz AM, Chaplin
T, Young BD, Ali M, Sugden D, Thurlow JK, Cheong SC, Teo SH, et al:
FOXM1 upregulation is an early event in human squamous cell
carcinoma and it is enhanced by nicotine during malignant
transformation. PLoS One. 4:e48492009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu W, Bi Y, Kong J, Zhang J, Wang B, Li K,
Tian M, Pan X, Shi B, Gu J, et al: Combination of an anti-EGFRvIII
antibody CH12 with Rapamycin synergistically inhibits the growth of
EGFRvIII+PTEN-glioblastoma in vivo. Oncotarget. 7:24752–24765.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wee P and Wang Z: Epidermal growth factor
receptor cell proliferation signaling pathways. Cancers (Basel).
9:E522017. View Article : Google Scholar : PubMed/NCBI
|
